Money Makers Mentor

Novalis Biotech Closes €25 Million Biotech Acceleration Fund

Novalis Biotech, an early-stage venture capital investor in healthcare technologies, has announced the closure of its €25 million second fund. Both new and returning investors have participated in the fundraising named the Novalis Biotech Acceleration Fund.

Novalis Biotech seeds biotechnology and life sciences-related companies. Novalis develops innovative investment ideas at the early stage and supports further evolution of the companies, by a combination of our contacts, experience, and complementary skills. Their investment ideas focus on the interaction between bioinformatics and life sciences. Moreover, the company says that they strongly believe in applying innovative information technology to advance prevention, diagnosis, or treatment of diseases.

Standard Bariatrics Secures…

Leave A Reply

Your email address will not be published.